GIS:FRA
Gilead Sciences, Inc
€१४९.५८
arrow_upward
+१.११%(+१.६४) १ दि
९ नोव्हें, १०:००:०० PM [GMT]+१ · EUR
search
सर्व सिम्बॉल
| सिम्बॉल | किंमत | बदल | % बदल |
|---|
insights_autoGIS साठी टॉप इनसाइट जनरेट करत आहे...
उघडा
€१५१.५४
उच्च
€१५१.५४
कमी
€१४९.५८
मार्केट कॅप
२.१० खर्व
सरासरी उलाढाल
१८२.००
उलाढाल
२९४.००
५२ आठवड्यांतील उच्चांक
€१५७.१४
५२ आठवड्यांतील नीचांक
€१००.४२
कर्मचाऱ्यांची संख्या
१७ ह
उघडा
€१५१.५४
उच्च
€१५१.५४
कमी
€१४९.५८
मार्केट कॅप
२.१० खर्व
सरासरी उलाढाल
१८२.००
उलाढाल
२९४.००
५२ आठवड्यांतील उच्चांक
€१५७.१४
५२ आठवड्यांतील नीचांक
€१००.४२
कर्मचाऱ्यांची संख्या
१७ ह
बातम्यांच्या स्टोरी
वेब स्रोत आणि बातमी भागीदारांकडून
MarketWatch
·
२ तासांपूर्वी
Gilead Sciences Inc. stock rises Monday, still underperforms market
Investor's Business Daily
·
२ तासांपूर्वी
Gilead Rival Shoots To Two-Year High On Hepatitis D News
BioSpace
·
६ तासांपूर्वी
Vir’s hepatitis delta combo tamps down virus as Gilead showdown looms
प्रोफाइल
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
Gilead Sciences, Inc बद्दल
CEOडॅनियेल ओडे
कर्मचारी१७ ह
स्थापना२२ जून, १९८७
मुख्यालयेFoster City, कॅलिफोर्निया, संयुक्त राष्ट्र
क्षेत्रHealth Care
उद्योग-
वेबसाइटgilead.com